Experimental psychiatrists have released their results from the first controlled medical trial of LSD in 40+ years
The study was published in the Journal of Nervous and Mental Disease . The study found compelling evidence that Lysergic acid diethylamide (LSD), when administerd in a controlled environment, lowers anxiety in individuals facing life-threatening illnesses. The sample size for the study only consisted of 12 test subjects.
Rick Doblin, executive director of the Multidisciplinary Association for Psychedelic Studies, which sponsored the study said, “This study is historic and marks a rebirth of investigation into LSD-assisted psychotherapy. The positive results and evidence of safety clearly show why additional, larger studies are needed.”
The new study reaffirms many findings from 40 years ago.
Researchers found 12 patients who were coping with anxiety associated with terminal illness. 8 patients were then selected to receive drug-free psychotherapy sessions as well as two LSD-assisted sessions 2 to 3 weeks apart. Four participants were given a placebo during therapy and they served as the control. LSD helps stimulate a deep psychedelic state, allowing the participants to reach what they described as an emotionally intensified state of being.
“My LSD experience brought back some lost emotions and ability to trust, lots of psychological insights, and a timeless moment when the universe didn’t seem like a trap, but like a revelation of utter beauty,” said Peter, an Austrian subject who participated in the study.
In a follow-up two months later, researchers noted a significant reduction in state anxiety. In contrast, anxiety actually increased for patients in the placebo group. Further, the reductions in anxiety were sustained for a full year in the group given LSD.
Can LSD help with anxiety? FDA OKs clinical trials after 40 year hiatus.